Archive: 19/02/2019

Extinguishing fear memories relies on an unusual change to DNA

QBI researchers have discovered a DNA modification that enhances our ability to extinguish fear.

Feb 19, 2019

0

147

PCSK9 inhibitors to lower cholesterol in patients with statin-associated autoimmune myopathy

Clinicians should consider using PCSK9 inhibitors to lower cholesterol in patients with statin-associated autoimmune myopathy. Findings from a case report are published in the Annals of Internal Medicine.

Feb 19, 2019

0

5

Study shows why high-protein diets are unhealthy

Researchers in South Australia believe they have found the key to why high-protein diets are unhealthy and can lead to shortened lifespans.

Feb 19, 2019

5

7419

Researchers identify a very early marker of cardiac damage triggered by cancer treatment

Every year, 4 million new cases of cancer are diagnosed in Europe. Advances in cancer treatment sometimes come at the cost of major adverse effects, and one of the most prominent is cardiotoxicity. Myocardial toxicity affects ...

Feb 19, 2019

0

2

Young Russians seek health, highs in ice swimming

Diving into a long hole cut in the ice, Viktoria Tsuranova swims a few strokes and flashes a smile at the photographer capturing the moment for her Instagram account.

Feb 19, 2019

0

7

Oral antifungal drug used to treat yeast infections linked to higher rates of miscarriage

A commonly used medication, fluconazole, used to treat vaginal yeast infections, is linked to higher rates of miscarriage if used during pregnancy, found new research published in Canadian Medical Association Journal.

Feb 19, 2019

0

1

Zoster recombinant vaccine provides better value and better protection against shingles

Vaccination with the new recombinant zoster vaccine (RZV) provides greater protection against shingles and is cost-effective compared with zoster vaccine live (ZVL) or no vaccination. Findings from a cost-effectiveness study ...

Feb 19, 2019

Despite rising prevalence of heart disease in China, primary preventive treatment rates remain low

About one in 10 middle-aged adults in China are at high risk for cardiovascular disease (CVD), yet use of risk reduction therapies is strikingly low. Findings from a Chinese national screening project are published in Annals ...

Feb 19, 2019

page 8 from 8

«
»